Developed by Eli Lilly, it is a single-molecule triple receptor agonist targeting three key metabolic hormone receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon
The CTR is also expressed at the cell surface independently of RAMPs and has a distinct phenotype, exhibiting potent responses to human, and other species of CT peptides, but weak responses to amylin
Umpierrez G, Tof Povedano S, Prez Manghi F, Shurzinske L, Pechtner V
The scientific case for it: A 2008 study published in the Journal of the International Society of Sports Nutrition reported that 14 days of CoQ10 increased trained athletes time to exhaustion in an endurance exercise test
In particular, Xiaoming et al
Effects of selenium on short-term control of hyperthyroidism due to graves disease treated with methimazole: Results of a randomized clinical trial